BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20010546)

  • 1. FGF23-parathyroid interaction: implications in chronic kidney disease.
    Komaba H; Fukagawa M
    Kidney Int; 2010 Feb; 77(4):292-8. PubMed ID: 20010546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
    Komaba H
    Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
    Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
    Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF23: a key player in mineral and bone disorder in CKD.
    Komaba H; Fukagawa M
    Nefrologia; 2009; 29(5):392-6. PubMed ID: 19820750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.
    Galitzer H; Ben-Dov IZ; Silver J; Naveh-Many T
    Kidney Int; 2010 Feb; 77(3):211-8. PubMed ID: 20016468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
    Komaba H; Goto S; Fujii H; Hamada Y; Kobayashi A; Shibuya K; Tominaga Y; Otsuki N; Nibu K; Nakagawa K; Tsugawa N; Okano T; Kitazawa R; Fukagawa M; Kita T
    Kidney Int; 2010 Feb; 77(3):232-8. PubMed ID: 19890272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
    Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
    Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
    Drüeke TB
    Kidney Int; 2010 Dec; 78(11):1057-60. PubMed ID: 21076444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
    Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF23 and the parathyroid.
    Silver J; Naveh-Many T
    Adv Exp Med Biol; 2012; 728():92-9. PubMed ID: 22396164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of parathyroid hormone in Klotho-FGF23 system].
    Kimura T; Shiizaki K; Kuro-O M
    Clin Calcium; 2016 Jun; 26(6):859-66. PubMed ID: 27230841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHEX, FGF23, DMP1 and beyond.
    Strom TM; Jüppner H
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):357-62. PubMed ID: 18660670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF23 fails to inhibit uremic parathyroid glands.
    Canalejo R; Canalejo A; Martinez-Moreno JM; Rodriguez-Ortiz ME; Estepa JC; Mendoza FJ; Munoz-Castaneda JR; Shalhoub V; Almaden Y; Rodriguez M
    J Am Soc Nephrol; 2010 Jul; 21(7):1125-35. PubMed ID: 20431039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 23/klotho axis in chronic kidney disease.
    Nitta K; Nagano N; Tsuchiya K
    Nephron Clin Pract; 2014; 128(1-2):1-10. PubMed ID: 25402964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
    Prié D; Friedlander G
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of FGF23 in CKD--with or without Klotho.
    Komaba H; Fukagawa M
    Nat Rev Nephrol; 2012 Jun; 8(8):484-90. PubMed ID: 22714041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
    Gutiérrez OM
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.